Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

morphine-naltrexone

morphine-naltrexone
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Embeda CAPSULE, EXTENDED RELEASE, ORAL 20 mg-0.8 mg, 30 mg-1.2 mg, 50 mg-2 mg, 60 mg-2.4 mg    
Embeda CAPSULE, EXTENDED RELEASE, ORAL 80 mg-3.2 mg, 100 mg-4 mg    
Comments:
Ordered Formulation Therapeutic Interchange

morphine-naltrexone (Embeda)

  • 20 mg-0.8 mg ER capsule BID
  • 30 mg-1.2 mg ER capsule BID
  • 50 mg-2 mg ER capsule BID
  • 60 mg-2.4 mg ER capsule BID
  • 80 mg-3.2 mg ER capsule BID
  • 100 mg-4 mg ER capsule BID

morphine

  • 15 mg ER tablet BID
  • 30 mg ER tablet BID
  • 60 mg ER tablet BID
  • 60 mg ER tablet BID
  • 60 mg ER tablet q8 hrs
  • 100 mg ER tablet BID

Embeda medication guide

Embeda is classified as non-formulary, not stocked or ordered. Generic sustained release morphine should be dispensed in place of Embeda in a similar dosing regimen and providing a similar amount of morphine per 24 hours. Naltrexone in Embeda tablets is inactive unless crushed or chewed.

Reviewed: December 15, 2009.

REMS (Embeda): View FDA REMS Info

Last updated: Dec. 18, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved